Recent Updates
Recently added Catalysts
IMDX Positive Sentiment Score: 85/100

NOW OFFICIALLY AVAILABLE!!! We are excited to announce the official launch of #VitaGraft Kidney! Previously only available through Oncocyte's Early Access Program, VitaGraft Kidney is now broadly available to transplant

Tuesday, January 23, 2024 1 min read
Key Takeaway: Oncocyte has officially launched the VitaGraft Kidney, making the blood-based test widely available to transplant professionals. Previously limited to an Early Access Program, this test measures donor-derived cell-free DNA concentrations post-kidney transplantation. It helps indicate potential organ damage and rejection, enhancing patient monitoring and care. The company has also updated its VitaGraft Kidney web page to support this launch.

Market Sentiment Analysis

POSITIVE FACTORS

  • VitaGraft Kidney is now widely available to transplant professionals.
  • The test serves as an important indicator for potential organ damage and rejection.

Full Press Release Details

OFFICIALLY AVAILABLE!!!
are excited to announce the official launch of #VitaGraft Kidney!
only available through Oncocyte's Early Access Program, VitaGraft Kidney is now broadly available to transplant professionals upon
Kidney is a blood-based test that measures donor-derived cell-free DNA (#dd-cfDNA) concentrations post-kidney #transplantation,
serving as an indicator for potential organ damage and rejection.
check out our newly designed VitaGraft Kidney web page!
https://hubs.li/Q02hhzvl0
#OCX #Innovation #WhereTomorrowLives $OCX
are excited to announce the #OfficialLaunch of #VitaGraft Kidney! Previously only available through Oncocyte's Early
Access Program, VitaGraft Kidney is now broadly available upon request.
#OCX #Innovation #WhereTomorrowLives

Frequently Asked Questions

What is the #VitaGraft Kidney test?

The #VitaGraft Kidney test measures donor-derived cell-free DNA concentrations post-transplant.

How can transplant professionals access VitaGraft Kidney?

VitaGraft Kidney is available to transplant professionals through Oncocyte's Early Access Program.

What does the VitaGraft Kidney test indicate?

The test indicates potential organ damage and rejection after kidney transplantation.

Is VitaGraft Kidney widely available now?

Yes, VitaGraft Kidney is now broadly available upon request.

Tags: IMDX Viatris Investor Conferences Healthcare VitaGraft Oncocyte kidney transplant dd-cfDNA biopharma
Last updated: Jan 23, 2024